The additional biomarker Glypican 3 (GPC3), which is widely used for the diagnosis of HCC, exhibited the same expression pattern in the PDOs and tumors (Fig. 2c), and the biliary marker EpCAM was absent from both (Fig. 2d). This evidence concerns the gene EPCAM and hepatocellular carcinoma.